Lummy obtained two drug registration certificates

Zhitong
2025.09.17 07:53
portai
I'm PortAI, I can summarize articles.

According to the Zhitong Finance APP, Lummy announced that the company has received the Drug Registration Certificates for two medications: Nicorandil Tablets (Specification: 5mg) and Ketorolac Tromethamine Injection (Specification: 1ml: 30mg) approved by the National Medical Products Administration. The announcement indicates that Nicorandil Tablets are used for the treatment of angina pectoris. Ketorolac Tromethamine Injection is suitable for the short-term treatment of moderate to severe acute postoperative pain

According to the Zhitong Finance APP, Lummy (300006.SZ) announced that the company has received the Drug Registration Certificates for two medications: Nicorandil Tablets (Specification: 5mg) and Ketorolac Tromethamine Injection (Specification: 1ml: 30mg) approved by the National Medical Products Administration. The announcement indicates that Nicorandil Tablets are used for the treatment of angina pectoris. Ketorolac Tromethamine Injection is suitable for the short-term treatment of moderate to severe acute postoperative pain

Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer